Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, Maryland

The mission of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is to go beyond the cutting edge in science and medicine to perform the most advanced research and translate the discoveries into the very best cancer therapies. The Kimmel Cancer Center, which opened in 1973, has active programs in clinical research, laboratory research, education, community outreach, and prevention and control.

The strength of its research and treatment programs was recognized early on by the National Cancer Institute (NCI). The center became one of the first to earn Comprehensive Cancer Center status and recognition as a “Center of Excellence,” and is one of only 41 cancer centers in the country designated as such. It is the only Comprehensive Cancer Center in the state of Maryland.

Website: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Contact:
Clinical Research Office
JHCCCRO@jhmi.edu
410-955-8866

Trials at this location:

HCRN GU16-243

PhAse I/II StuDy of Modern ImmunotherApy in BCG-RelaPsing UroThelial Carcinoma of the BLADDER – (ADAPT-BLADDER) HCRN GU16-243

Status: Open to Accrual
Read More

HCRN GU14-182

A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer: HCRN GU14-182

Status: Closed to Accrual
Read More

HCRN GU15-217

UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch: Hoosier Cancer Research Network GU15-217

Status: Closed to Accrual
Read More

HCRN GU15-262

Phase 2 Trial of Olaparib in Patients with Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations

Status: Closed to Accrual
Read More

HCRN GU16-287

Randomized phase 2 trial of gemcitabine + carboplatin + nivolumab versus gemcitabine + oxaliplatin + nivolumab in cisplatin-ineligible patients with metastatic urothelial cancer

Status: Closed to Accrual
Read More

TBCRC029

Clinical and Biological Characterization of Male Breast Cancer: an International EORTC, BIG, TBCRC and NABCG Intergroup Study.

Status: Closed to Accrual
Read More

TBCRC035

Palbociclib in Combination with Fulvestrant or Tamoxifen as Treatment for Hormone Receptor Positive Metastatic Breast Cancer with Prior Chemotherapy for Advanced Disease: A Phase II study with Pharmacodynamics Markers (TBCRC035)

Status: Closed to Accrual
Read More